Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry
Lipid Imaging in Traumatic Brain Injury by High Resolution GCIB-secondary Ion Mass Spectrometry
批准号:
10657873
负责人:
Hülya Bayir
金额:
$59.32万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-07-01 至 2028-07-31
关键词:
AddressAgeAmidesAnabolismAnti-Inflammatory AgentsArachidonate 15-LipoxygenaseArachidonic AcidsAreaAutomobile DrivingBinding ProteinsBiologyBrainBrain InjuriesCause of DeathCell DeathCellsCessation of lifeClinicalCoenzyme A LigasesComplexDataEmploymentEndocannabinoidsEvaluationFamily memberGasesGenerationsGoalsImageImaging TechniquesImaging technologyIndividualInflammationInflammatoryInflammatory ResponseInjuryIntracranial HypertensionIonsLabelLanthanoid Series ElementsLateralLipid PeroxidationLipidsLiquid ChromatographyMapsMechanicsMethodsMinorModelingMolecularMusNecrosisOxidation-ReductionPathogenesisPathway interactionsPhosphatidylethanolaminePhospholipidsPositioning AttributeProcessProteinsProtocols documentationReactionRefractoryRegulationResolutionRoleScaffolding ProteinSecondary toSeriesSignal TransductionSpecificitySpectrometry, Mass, Secondary IonTBI PatientsTechnologyTestingThree-Dimensional ImagingTimeTissuesTraumatic Brain InjuryWateracyl groupamino groupanandamideantibody conjugatebrain tissuecatalystcell typecontrolled cortical impactdesigndisabilityeffectiveness evaluationhigh resolution imaginginhibitorinnovationlipidomicsmass spectrometric imagingmetermultiple omicsneuropathologynoveloxidationperoxidationprogramsprotein complexsmall moleculetargeted treatmenttransacylationyoung adult
中文摘要
创伤性脑损伤(TBI)是所有年龄段的死亡和残疾的主要原因。继发性损伤
磷脂过氧化和细胞死亡的机制暗示了损伤的扩大
由最初的侮辱造成的。我们发现,坏死性细胞死亡的一个必要步骤,铁性下垂,引发了
以花生四氢叶酸-磷脂酰乙醇胺(A-PE)为底物,催化A-PE过氧化。
15-脂氧合酶(15LOX)和PE结合蛋白(PEBP1)。我们还发现,酰基辅酶A合成酶
长链4(ACSL4)负责A-PE的合成,是一种重要的正性铁下垂调节剂。
然而,有两个问题:1)在铁性下垂中,哪些细胞类型经历PE氧化;2)为什么发生铁性下垂
由于大脑中A-PE含量较高,敏感性取决于ACSL4-由于缺乏A-PE而仍未得到回答
不同细胞类型的各种脂类的亚细胞分辨率成像。为了回答问题1,我们
开发创新的双二次离子质谱仪(SIMS)成像工作流程
用水煤气团簇离子束((H2O)n-GCIB)-SIMS结合稀土元素标记蛋白质
结合抗体(最多40个)。这使得在同一组织切片上进行亚细胞定位成为可能。
单独的PL,包括氧化的PL(PLOX),灵敏度和横向分辨率提高~100-1000倍
~1微米,并鉴定正在经历脂质过氧化的细胞类型。为了解决第二个问题,我们开发了
基于液质联用的氧化还原脂质组学方法定量检测轻微的脂质过氧化
底物不仅在铁性下垂的进展过程中,而且在其开始的时候。我们发现那次入会
通过少量可氧化的具有花生四烯酰基残基的二-花生四烯酸-PE(di-A-PE)的过氧化作用而发生
在sn-1和sn-2两个位置。初步数据显示,15LOX本身就很容易氧化di-A-PE,领先
开始出现铁性下垂。通常,di-A-PE用于合成内源性大麻素,特别是
花生四甲酰基酰胺(双乙酰胺)。该途径利用di-A-PE的sn-1酰基进行酶促转酰化。
另一种PE的氨基,生成N-酰基-PE(NAPE)。在铁性下垂的情况下,N-转酰化
是15-LOX氧化di-A-PE的有力竞争者。因此,需要ACSL4的di-AA-PE合成可能是
上睑下垂的瓶颈。我们的中心假设是:i)脑外伤引起的下垂是一个两阶段的过程
由二-A-PE过氧化引发,然后是单一A-PE物种被氧化的繁殖阶段
在较低的比率下;ii)与NAPE/ANANDAME相比,di-A-PE的形成是铁性下垂敏感性的决定性因素
颅脑损伤后形成。我们的具体目标包括:1.优化分子的SIMS成像方案
正常和损伤脑中不同细胞类型的plx及其底物的特征。2.确定
ACSL4和NAPE在不同类型损伤细胞脂质过氧化的分子特异性中的作用
大脑。3.利用单细胞SIMS成像评价基于新机制的选择性治疗的有效性
铁下垂抑制剂:1)双烯丙基去氢花生四烯酸,2)15LOX/PEBP1复合体的抑制剂。
英文摘要
Traumatic brain injury (TBI) is a major cause of death and disability across all ages. Secondary injury
mechanisms of phospholipid (PL) peroxidation and cell death are implied in the expansion of the damage
caused by the primary insult. We discovered that a required step in necrotic cell death, ferroptosis, triggered
by TBI is peroxidation of arachidonoyl-phosphatidylethanolamine (A-PE) catalyzed by enzymatic complex of
15-lipoxygenase (15LOX) with PE-binding protein (PEBP1). We also showed that acyl-CoA synthetase
long-chain 4 (ACSL4), responsible for A-PE synthesis, is an essential positive ferroptosis regulator.
However, two questions: 1) Which cell types undergo PE oxidation in ferroptosis, and 2) Why ferroptosis
sensitivity depends on ACSL4 given high content of A-PE in the brain – remain unanswered due to lack of
subcellular-resolution imaging of diversified lipids in different cell types. To address question 1, we
developed innovative dual- secondary ion mass spectrometry (SIMS) imaging workflow whereby imaging
with water gas cluster ion beams ((H2O)n-GCIB)-SIMS was combined with labeling of proteins by lanthanide
conjugated antibodies (up to ~40). This allowed subcellular mapping on the same tissue section of
individual PLs, including oxidized PLs (PLox) with ~100-1,000 times higher sensitivity and lateral resolution
~1µm and identificiation of cell types undergoing lipid peroxidation. To address question 2, we developed
liquid chromatography-MS-based redox lipidomics approaches to quantitate minor lipid peroxidation
substrates not only during the progression of ferroptosis but also at its initiation. We found that initiation
occurs via peroxidation of a minor oxidizable di-Arachidonoyl-PE (di-A-PE) which has arachidonoyl residues
in both sn-1 and sn-2 positions. Preliminary data show that 15LOX alone readily oxidizes di-A-PE, leading
to ferroptosis initiation. Normally di-A-PE is utilized for synthesis of endocannabinoids, particularly
arachidonoyl-amide (anandamide). This pathway utilizes sn-1 acyl of di-A-PE to enzymatically transacylate
the amino group of another PE, yielding N-acyl-PE (NAPE). In the context of ferroptosis, the N-transacylation
is a strong competitor of di-A-PE oxidation by 15-LOX. Thus, di-AA-PE synthesis, requiring ACSL4, might be
a ferroptosis bottleneck. Our central hypotheses are: i) TBI-induced ferroptosis is a two-stage process
initiated by di-A-PE peroxidation followed by the propagation stage where mono-A-PE species get oxidized
at a lower rate; ii) di-A-PE formation is decisive factor in sensitivity to ferroptosis vs NAPE /anandamide
formation after TBI. Our specific aims include: 1. Optimize SIMS imaging protocols for molecular
characterization of PLox and their substrates in different cell types in normal and injured brains. 2. Determine
the role of ACSL4 and NAPEs in molecular specificity of lipid peroxidation in different cell types of injured
brain. 3. Utilize single cell SIMS imaging to evaluate the effectiveness of novel mechanism based selective
ferroptosis inhibitors: 1) bis-allylic deuterated arachidonic acid, and 2) inhibitor of 15LOX/PEBP1 complex.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/bi301024e
发表时间:
2012-12-04
期刊:
Biochemistry
影响因子:
2.9
作者:
[Tyurin VA, Yanamala N, Tyurina YY, Klein-Seetharaman J, Macphee CH, Kagan VE]
通讯作者:
Kagan VE
DOI:
10.1016/j.freeradbiomed.2014.07.042
发表时间:
2014-11
期刊:
FREE RADICAL BIOLOGY AND MEDICINE
影响因子:
7.4
作者:
[Mohammadyani, Dariush, Tyurin, Vladimir A., O'Brien, Matthew, Sadovsky, Yoel, Gabrilovich, Dmitry I., Klein-Seetharaman, Judith, Kagan, Valerian E.]
通讯作者:
Kagan, Valerian E.
DOI:
10.1038/s41418-023-01195-0
发表时间:
2023-09
期刊:
CELL DEATH AND DIFFERENTIATION
影响因子:
12.4
作者:
[Van San, Emily, Debruyne, Angela C. C., Veeckmans, Geraldine, Tyurina, Yulia Y. Y., Tyurin, Vladimir A. A., Zheng, Hao, Choi, Sze Men, Augustyns, Koen, van Loo, Geert, Michalke, Bernhard, Venkataramani, Vivek, Toyokuni, Shinya, Bayir, Huelya, Vandenabeele, Peter, Hassannia, Behrouz, Vanden Berghe, Tom]
通讯作者:
Vanden Berghe, Tom
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
-
批准号:10844023
-
项目类别:
-
资助金额:$33.61万
-
财政年份:2023
-
负责人:Hülya Bayir
-
依托单位:
Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
-
批准号:10838232
-
项目类别:
-
资助金额:$48.07万
-
财政年份:2023
-
负责人:Hülya Bayir
-
依托单位:
Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
-
批准号:10436895
-
项目类别:
-
资助金额:$47.54万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
-
批准号:10625932
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
-
批准号:10592289
-
项目类别:
-
资助金额:$56.93万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
-
批准号:10090670
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Druggable Mitochondrial Targets for Treatment of Cerebral Ischemia
-
批准号:10328870
-
项目类别:
-
资助金额:$56.93万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Radiation Mitigators Targeting Regulated Necrosis Pathways of Parthanatos Pyroptosis
-
批准号:10212243
-
项目类别:
-
资助金额:$46.79万
-
财政年份:2020
-
负责人:Hülya Bayir
-
依托单位:
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain
-
批准号:8820302
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2014
-
负责人:Hülya Bayir
-
依托单位:
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain
-
批准号:9193104
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2014
-
负责人:Hülya Bayir
-
依托单位:
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain
-
批准号:8994750
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2014
-
负责人:Hülya Bayir
-
依托单位:
Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in the Developing Brain
-
批准号:8733232
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2014
-
负责人:Hülya Bayir
-
依托单位:
Mapping Lipid Oxidation in Traumatic Brain Injury by Mass Spectrometric Imaging
-
批准号:8370521
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Mapping Lipid Oxidation in Traumatic Brain Injury by Mass Spectrometric Imaging
-
批准号:8481604
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Mapping Lipid Oxidation in Traumatic Brain Injury by Mass Spectrometric Imaging
-
批准号:8683264
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Mapping Lipid Oxidation in Traumatic Brain Injury by Mass Spectrometric Imaging
-
批准号:9093850
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Lipid imaging in Traumatic Brain Injury by high resolution GCIB-secondary ion mass spectrometry
-
批准号:10199056
-
项目类别:
-
资助金额:$54.9万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Lipid imaging in Traumatic Brain Injury by high resolution GCIB-secondary ion mass spectrometry
-
批准号:10454918
-
项目类别:
-
资助金额:$54.22万
-
财政年份:2012
-
负责人:Hülya Bayir
-
依托单位:
Radiation Mitigators Based on MnSOD Responses to Oxidative and Nitrosadative Stre
-
批准号:8010799
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2010
-
负责人:Hülya Bayir
-
依托单位:
Role of Cardiolipin Oxidation After Traumatic Brain Injury in Immature Rat
-
批准号:7929372
-
项目类别:
-
资助金额:$9.08万
-
财政年份:2009
-
负责人:Hülya Bayir
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: